lowest cost glp 1 Feds, Pharma Companies Strike Deal for Low GLP-1 Medications π GLP-1 medications starting as
Description
doi: 10.1016/j.cmet.2014.07.012
These allow GLP-1 receptor agonists manufacturers to run production that is consistent and predictable

Potent body weight loss, and therapeutic efficacy in a NASH animal model by a novel long-acting GLP-1/Glucagon/GIP tri-agonist (HM15211)
My take: GLP-1RAs may become more than metabolic drugs, but oncology needs prospective cancer-outcome data before calling this prevention
Epithelial Notch signaling is a limiting step for pancreatic carcinogenesis

Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP-1 receptor agonism in patients with type 2 diabetes